JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
LXRX Financials - Lexicon Pharmaceuticals Income & Cash Flow | Ledgeburg
LXRX - Lexicon Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary LXRX Stock
Financials
Financials LXRX Stock
Loading...
Loading...
Income Statement
Income Statement LXRX Stock
Balance Sheet
Balance Sheet LXRX Stock
Cash Flow Statement
Cash Flow Statement LXRX Stock
Loading...
Loading...
Home
Stocks
Lexicon Pharmaceuticals, Inc. (LXRX)
Financials
Financials of LXRX
Loading...
Loading...
Loading...
Loading...
Revenue
$49.803M
Operating Income
$-48.911M
Net Income
$-50.341M
Share Count (Basic)
363.053M
Operating Cash Flow
$-67.851M
Free Cash Flow
$-67.851M
Cash And Short-Term Equivalents
$96.23M
Total Debt
$54.003M
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
50M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
10M
20M
30M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-200M
-150M
-100M
-50M
Annual
Quarterly
Margins
Gross
Operating
Net
-80000%
-60000%
-40000%
-20000%
0%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-20M
-10M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2000%
-1500%
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26